By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioNovo, Inc. 

5858 Horton Street
Suite 375
Emeryville  California  94608  U.S.A.
Phone: 510-601-2000 Fax: 510-601-5050



Drug Discovery

Company News
BioNovo, Inc. (BNVI) Skincare Introduces the Upper Lip Treatment Product. 4/1/2013 10:05:14 AM
BioNovo, Inc. (BNVI) Selects GoIndustry DoveBid’s BioPharma Exchange Program as Its Surplus Assets Sales Channel of Choice 6/12/2012 10:24:34 AM
BioNovo, Inc. (BNVI) Announces 2011 Highlights and Year-End Financial Results 4/2/2012 11:01:31 AM
BioNovo, Inc. (BNVI)'s Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 3/28/2012 10:52:30 AM
BioNovo, Inc. (BNVI) Reduces Workforce by Over 90%; Management Compensation Restructured 3/12/2012 6:51:42 AM
BioNovo, Inc. (BNVI) President & CMO Receives Women of the Year Award 3/8/2012 11:49:59 AM
BioNovo, Inc. (BNVI) to Present at Cowen and Company 32nd Annual Health Care Conference 3/1/2012 10:47:04 AM
BioNovo, Inc. (BNVI) Files Registration Statement for Offering of Convertible Preferred Stock and Warrants 3/1/2012 9:14:01 AM
BioNovo, Inc. (BNVI) Announces Decision to Explore Strategic Options and to Delay Announcement of Financial Results for 2011 2/21/2012 11:03:10 AM
BioNovo, Inc. (BNVI) to Host Conference Call to Discuss 2011 Highlights and Year-End Financial Results 2/16/2012 9:55:37 AM